Whole genome sequencing in paediatric channelopathy and cardiomyopathy
Channelopathy
Exome
DOI:
10.3389/fcvm.2024.1335527
Publication Date:
2024-03-20T05:20:43Z
AUTHORS (9)
ABSTRACT
Precision medicine in paediatric cardiac channelopathy and cardiomyopathy has a rapid advancement over the past years. Compared to conventional gene panel exome-based testing, whole genome sequencing (WGS) offers additional coverage at promoter, intronic regions mitochondrial genome. However, data on use of WGS evaluate genetic cause these cardiovascular conditions children adolescents are limited.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....